BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7933079)

  • 1. Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.
    Dai HY; Faxvaag A; Troseth GI; Aarset H; Dalen A
    J Virol; 1994 Nov; 68(11):6976-84. PubMed ID: 7933079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.
    Dai HY; Troseth GI; Gunleksrud M; Bruland T; Solberg LA; Aarset H; Kristiansen LI; Dalen A
    J Virol; 1998 Feb; 72(2):1244-51. PubMed ID: 9445024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
    Masuda M; Remington MP; Hoffman PM; Ruscetti SK
    J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early dissemination rates of Friend murine leukaemia virus variants correlate with late pathogenesis.
    Bruland T; Dai HY; Lavik LA; Dalen A
    APMIS; 2002 Dec; 110(12):899-912. PubMed ID: 12645669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus.
    Oliff A; McKinney MD; Agranovsky O
    J Virol; 1985 Jun; 54(3):864-8. PubMed ID: 3999195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glucocorticoid response element in the LTR U3 region of Friend murine leukaemia virus variant FIS-2 enhances virus production in vitro and is a major determinant for sex differences in susceptibility to FIS-2 infection in vivo.
    Bruland T; Lavik LAS; Dai HY; Dalen A
    J Gen Virol; 2003 Apr; 84(Pt 4):907-916. PubMed ID: 12655091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
    Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E
    J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2.4-kilobase-pair fragment of the Friend murine leukemia virus genome contains the sequences responsible for friend murine leukemia virus-induced erythroleukemia.
    Oliff A; Ruscetti S
    J Virol; 1983 Jun; 46(3):718-25. PubMed ID: 6574260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses.
    Oliff A; Signorelli K; Collins L
    J Virol; 1984 Sep; 51(3):788-94. PubMed ID: 6088801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses.
    Sitbon M; Ellerbrok H; Pozo F; Nishio J; Hayes SF; Evans LH; Chesebro B
    J Virol; 1990 May; 64(5):2135-40. PubMed ID: 2182908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.
    Corbin A; Prats AC; Darlix JL; Sitbon M
    J Virol; 1994 Jun; 68(6):3857-67. PubMed ID: 8189523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
    Mukhopadhyaya R; Richardson J; Nazarov V; Corbin A; Koller R; Sitbon M; Wolff L
    J Virol; 1994 Aug; 68(8):5100-7. PubMed ID: 7518530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus.
    Takase-Yoden S; Watanabe R
    Virology; 1997 Jul; 233(2):411-22. PubMed ID: 9217064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus.
    Oliff AI; Hager GL; Chang EH; Scolnick EM; Chan HW; Lowy DR
    J Virol; 1980 Jan; 33(1):475-86. PubMed ID: 6245244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2.
    Bruland T; Dai HY; Lavik LAS; Kristiansen LI; Dalen A
    J Gen Virol; 2001 Aug; 82(Pt 8):1821-1827. PubMed ID: 11457987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At least four non-env factors that reside in the LTR, in the 5'-non-coding region, in gag and in part of pol affect neuropathogenicity of PVC-441 murine leukemia virus (MuLV).
    Tanaka A; Saida K; Andoh M; Maeda K; Kai K
    Virus Res; 2000 Aug; 69(1):17-30. PubMed ID: 10989182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus.
    Penciolelli JF; Wendling F; Robert-Lezenes J; Barque JP; Tambourin P; Gisselbrecht S
    J Virol; 1987 Feb; 61(2):579-83. PubMed ID: 3027384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system.
    Zhang F; Ya LT; Iwatani Y; Higo K; Suzuki Y; Tanaka M; Nakahara T; Ono T; Sakai H; Kuribayashi K; Ishimoto A
    J Virol; 2000 Jul; 74(13):6193-7. PubMed ID: 10846105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.